Literature DB >> 7211208

The demonstration of recurrent demyelination and remyelination of axons in the central nervous system.

E S Johnson, S K Ludwin.   

Abstract

A model for studying recurrent demyelination and remyelination in the central nervous system was developed by means of repeated administration of Cuprizone to mice. In contrast to the demyelination seen during the first course of Cuprizone, the recurrent demyelination was markedly protracted, displayed features of a "dying-back" gliopathy, and resulted in a greatly reduced inflammatory and glial reaction. The repeat remyelination also occurred at a slower tempo, varied markedly in completeness, and was associated with a diminished regeneration of oligodendrocytes. These results demonstrated that axons of the central nervous system in this model can be recurrently remyelinated if oligodendrocytes are available, that regeneration of oligodendrocytes is dependent upon the tissue reaction to demyelination, and that remyelinated axons are not more susceptible to demyelination than normal ones.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7211208     DOI: 10.1007/bf00689988

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  29 in total

1.  Attempts to induce chronic experimental allergic neuritis in strain 13 and Hartley guinea pigs.

Authors:  D H Snyder; S H Stone; C S Raine
Journal:  J Neuropathol Exp Neurol       Date:  1977-05       Impact factor: 3.685

2.  Regeneration of myelin in multiple sclerosis. The role of mesenchymal cells in such regeneration and in myelin formation in the peripheral nervous system.

Authors:  I Feigin; N Popoff
Journal:  Neurology       Date:  1966-04       Impact factor: 9.910

3.  Hypertrophic neuropathy.

Authors:  P K Thomas; R G Lascelles
Journal:  Q J Med       Date:  1967-04

4.  Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone.

Authors:  W F Blakemore
Journal:  J Neurol Sci       Date:  1973-09       Impact factor: 3.181

5.  Variation in the response of mice to cuprizone.

Authors:  S Elsworth; J M Howell
Journal:  Res Vet Sci       Date:  1973-05       Impact factor: 2.534

6.  An untrastructural analysis of remyelination following segmental demyelination.

Authors:  G Allt
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

7.  Experimental hypertrophic neuropathy. Pathogenesis of onion-bulb formations produced by repeated tourniquet applications.

Authors:  P J Dyck
Journal:  Arch Neurol       Date:  1969-07

8.  Spongiform encephalopathy induced in rats and guinea pigs by cuprizone.

Authors:  W W Carlton
Journal:  Exp Mol Pathol       Date:  1969-06       Impact factor: 3.362

9.  Electron microscope observations on demyelination and remyelination in experimental allergic neuritis. 2. Remyelination.

Authors:  R H Ballin; P K Thomas
Journal:  J Neurol Sci       Date:  1969 Mar-Apr       Impact factor: 3.181

10.  Remyelination in multiple sclerosis.

Authors:  J W Prineas; F Connell
Journal:  Ann Neurol       Date:  1979-01       Impact factor: 10.422

View more
  11 in total

1.  Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination.

Authors:  J L Mason; P Ye; K Suzuki; A J D'Ercole; G K Matsushima
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

2.  Glial Response to Intranasal Mesenchymal Stem Cells in Intermittent Cuprizone Model of Demyelination.

Authors:  Davood Zarini; Parichehr Pasbakhsh; Maryam Shabani; Sina Mojaverrostami; Maedeh Hashemi; Shiva Amirizadeh; Jamal Majidpoor; Ameneh Omidi; Keywan Mortezaee; Iraj Ragerdi Kashani
Journal:  Neurotox Res       Date:  2022-09-02       Impact factor: 3.978

3.  Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.

Authors:  Jeffrey L Mason; Arrel Toews; Janell D Hostettler; Pierre Morell; Kinuko Suzuki; James E Goldman; Glenn K Matsushima
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

4.  Benign form of multiple sclerosis: MRI evidence for less frequent and less inflammatory disease activity.

Authors:  D Kidd; A J Thompson; B E Kendall; D H Miller; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

5.  An immunohistochemical study of myelin proteins during remyelination in the central nervous system.

Authors:  S K Ludwin; N H Sternberger
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

6.  Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis.

Authors:  Robert A Brown; Sridar Narayanan; Douglas L Arnold
Journal:  Neuroimage Clin       Date:  2014-08-15       Impact factor: 4.881

7.  Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination.

Authors:  Enrique Garea Rodriguez; Christiane Wegner; Mario Kreutzfeldt; Katharina Neid; Dietmar R Thal; Tanja Jürgens; Wolfgang Brück; Christine Stadelmann; Doron Merkler
Journal:  Acta Neuropathol       Date:  2014-02-25       Impact factor: 17.088

8.  Laquinimod Supports Remyelination in Non-Supportive Environments.

Authors:  Stella Nyamoya; Julia Steinle; Uta Chrzanowski; Joel Kaye; Christoph Schmitz; Cordian Beyer; Markus Kipp
Journal:  Cells       Date:  2019-10-31       Impact factor: 6.600

9.  Extracellular acidic pH inhibits oligodendrocyte precursor viability, migration, and differentiation.

Authors:  Anna Jagielska; Kristen D Wilhite; Krystyn J Van Vliet
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

Review 10.  Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.

Authors:  Viktoria Gudi; Stefan Gingele; Thomas Skripuletz; Martin Stangel
Journal:  Front Cell Neurosci       Date:  2014-03-13       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.